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The influence of ultraviolet B irradiation in therapeutic doses 
on MHC II-positive epidermal cell numbers and their surface 
MHC II antigen expression was studied quantitatively using 
light microscopic immunoperoxidase and immunogold elec-
tron microscopic techniques. In multiple ultrathin sections 
through many MHC II-positive epidermal cells from five 
healthy subjects, prior to ultraviolet exposure, Langerhans 
cells and indeterminate cells were found to express similar 
densities of surface MHC II antigens, which were uniformly 
distributed over the cell surface. The variation in surface 
MHC II antigen expression on 97 dendritic epidermal cells 
U ltraviolet (UV) radiation is widely used to treat a variety of immunologicaUy mediated dermatoses. Because UV radiation has been shown to have im-munosuppressive effects in both humans and experi-mental animals [1-3], it is possible that UV-in-
duced immunomodulation might contribute to the therapeutic 
properties of UVB rad~ati~n. The precise mech~nism of UV -in-
duced immunomodulatlOn IS unknown, although It has been shown 
that both UVB and PUV A therapy impair the induction and elicita-
tion of allergic contact dermatitis in man in lIillo [4,5], and influence 
the function of epidermal antigen-presenting cells in vitro [1,2] . 
Epidermal Langerhans cells and indeterminate cells are the prin-
cipal antigen-presenting cells of human skin and, with the excep-
tion of acrosyringial keratinocytes, are the only epidermal cells to 
express surface major histocompatibility class II antigens (MHC II) 
in normal skin [6] . Epidermal Langerhans cells have been shown to 
be reduced in number (7,8], and morphologically altered, and/or 
their surface-antigen expression changed [9,10] after UVB expo-
sure. Such changes might be responsible for the local immunosup-
pression associated with UVB irradiation. However, it is still un-
clear whether low-dose UVB quantitatively alters Langerhans cell 
surface MHC II expression, destroys Langerhans cells, or causes 
them to emigrate from the epidermis. Some reports have demon-
strated reduced Langerhans cell surface MHC II expression follow-
ing low-dose UVB in vivo [11], but others have demonstrated reten-
tion in vitro or even enhancement of surface antigen in vivo [9,12] . 
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from one subject was normally distributed. Following a 
6-week course of ultraviolet B irradiation, in the same doses 
as those normally used for the treatment of psoriasis, MHC 
II - positive epidermal cell numbers were significant! y re-
duced (mean decrease to 51 % of the pre-UVB sample; p < 
0.001 analysis of variance), but their surface MHC class II 
antigen density was significantly increased (p < 0.05 analysis 
of variance). No MHC II -negative Langerhans cells were 
detected in either the pre- or post-UVB samples. ] Irwest 
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Furthermore, in experimental animals, UV -induced alterations in 
Langerhans cell morphology in vivo may occur independently of 
measurable immunologic effects [13,14] . 
Most previous studies have been undertaken either in vitro or in 
experimental animals, or have used UVB regimens in human volun-
teers that differed considerably from those used therapeutically. 
The aim of this study was to examine the influence of a UVE • 
regimen commonly used for treating psoriasis on the surface MHC 
II expression and numbers of Langerhans cells from normal subjects, 
a more life-like situation than in most other studies. 
MATERIALS AND METHODS 
Subjects and UVB Phototherapy Five healthy subjects (three 
men, two women; mean age 42.8 years, age range 28 - 58 years) 
with skin types II - III received the UVB regimen normally used for 
treating psoriasis in our department. They were irradiated with 
incremental doses ofUVB in a Waldmann 1000 UVB cabinet con-
taining 26 Sylvania UV6 tubes, emitting 0.93 mW /cm2 UVB and 
0.03 m W /cm2 UVA, thrice weekly for 6 weeks between August 
and December. The initial UVB dose was 37 mJ/cm2 , which was 
then increased by 50%, and subsequently by smaller increments, to a 
minimum of 15%. This regimen of UVB was intended to be sub-
erythemal. If a subject experienced erythema, the UVB dose was not 
increased until the inflammation settled. The volunteers received a 
mean total UVB dose of 4.89 J/ cm2 each (range 4 - 6 J/ cm2), equiva-
lent to a mean of 29.6 minimal erythema doses, a dose normally 
sufficient to clear stable plaque psoriasis. During irradiation, sub-
jects wore clothing that left the arms completely uncovered and 
they refrained from exposing their skin to sunlight between treat-
ments. 
Twenty suction blisters, each measuring 5 mm in diameter, were 
raised on the flexor aspects of the upper and lower arms before UVE 
irradiation (pre UVB) and 48 h after the final UVB dose (post 
UVB), using four suction blister cups at a pressure of 150 mm Hg 
below atmospheric, as described previously [15,16]. The blister 
0022-202X/93/$06.00 Copyright © 1993 by The Society for Investigative Dermatology, Inc. 
16 
VOL. 100, NO. 1 JANUARY 1993 
roofs were excised and divided for immunohistochemical and im-
munogold labeling of Langerhans cell surface MHC II. 
Immunohistochemical Staining of Suction Blister Roofs 
AIr-dried 6-,um vertical cryostat sections through blister roofs from 
the forearm were stained with an anti-Pan MHC II (DP, DQ, DR) 
tn.onoclonal antibody [17], DA6.231 (kindly donated by Dr. K. 
Guy, Edinburgh, U.K.), diluted 1; 10 in 20% normal rabbit serum 
as described previously [6]. Control sections were incubated in 20% 
nor.mal rabbit serum alone as a negative control or were stained with 
antl-CDla (OKT6) antibody (Becton Dickinson, CAl as a positive 
Control. The sections were washed twice in Tris-buffered saline 
thenincubated for 45 min with horseradish peroxidase-conjugated 
rabbit anti-mouse antibody, diluted 1; 20 in 20% normal rabbit 
serum. Peroxidase activity in the sections was revealed by a 5-min 
Incubation in diaminobenzidine. Sections were counterstained·with 
Mayer's hemalum and the numbers ofDA6.231-positive epidermal 
cells were counted per mm of epidermal basal cell plasma mem-
brane, measured by planimetry on photomicrographs. This tech-
nique was used to examine the number of MH C II - positi ve epider-
~lal cells on five sections per subject before and after UVB 
Irradiation. 
Pr~paration of Epidermal Cells for Immunogold Labeling E~Idermal cell suspensions were prepared by incubating suction 
?hster roofs in 0.25% trypsin (Flow Laboratories, Irvine, Scotland) 
111 Hanks' buffered salt solution for 1 h at 37°C. Epidermal cells 
Were washed twice in RPMI 1640 medium (Flow Laboratories), 
Containing 15% heat-inactivated fetal calf serum, and their viability 
determined by trypan blue exclusion (always> 80%). 
Epidermal cells (106 cells/ml) were prefixed in periodate 
(0.01 M) -lysine (0.075 M) - paraformaldehyde (2%) for 30 min, 
washed in 0.1 M cacodylate buffer (pH 7.4), their Fc receptors b~ocked with phosphate-buffered saline (PBS) containing 1 % bo-
Vl\1e serum albumin (BSA), 0.2% sodium azide, and 10% decomple-
lllented human AB serum for 30 min, and then spun and washed in 
P~S containing 0.1 % BSA [18]. Epidermal cells were then labeled 
With DA6.231 diluted 1:10 in PBS-l% BSA for 30 min and 
w~shed in PBS 0.1 % BSA. Finally, epidermal cells were incubated 
With a goat anti-mouse secondary antibody conjugated to 15- or 
30-nm gold particles (Janssen Pharmaceutica, Beerse, Belgium), 
dIluted 1 ; 2 in PBS 1 % BSA, for 60 min [19]. Controls were created 
by the omission of the primary antibody, or its substitution with an 
Irrelevant antibody (anti-alpha fetoprotein; Serotec, Oxford, UK) 
of the same isotype (IgG 1) as DA6.231. 
~rocessing of Epidermal Cells for Immunogold Transmis-
SIon Electron Microscopy Epidermal cells were spun and then 
washed in cacodylate buffer (pH 7.2), fixed in 2% formaldehyde 
and 2.5% glutaraldehyde in 0.04 M cacodylate buffer, containing 
0.03% calcium chloride and 5% sucrose (pH 7.4), and post-fixed in 
2% osmium tetroxide. The cells were dehydrated in a graded series 
of ~thanol and embedded as a pellet of cells in Araldite CY212 (Agar 
SCientific Ltd., Essex,' UK). Ultrathin sections of a pale-gold inter-fe~ence color were cut on an LKB III ultramicrotome, post-stained 
With uranyl acetate and lead citrate, and viewed with a Philips 
EM301 electron microscope. 
The precise thickness of pale-gold sections was determined by 
r~-embedding 22 of these sections in Araldite and resectioning at 
tight angles to the original plane of the section. The mean thickness 
Was then measured directly from electron micrographs. 
Distribution of Epidermal Cell Surface MHC II In order to 
Investigate the distribution ofMHC II over the surface of individual 
Langerhans cells, epidermal cell suspensions were prepared from all 
five subjects before and after UVB irradiation and incubated with 
DA6.231 and secondary antibody conjugated to 30-nm gold parti-
cles. The numbers of gold particles per /1m plasma membrane were 
then determined in three to five step sections through each of 15 
Langerhans cells (three Langerhans cells from each subject). Step 
Sections were separated by approximately 1 /1m (every 20ili section 
Was examined) and all DA6.231-positive epidermal cells in that 
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Table I. Number of DA6.231-Positive Cells Before and After 
a Standard 6-Week Course of UVB Radiation" 
Subject Pre UVB Post UVB 
1 23.25 ± 7.15 16.04 ± 5.63 
2 29.26 ± 3.91 10.67 ± 4.07 
3 22.89 ± 3.26 9.95 ± 3.64 
4 19.91 ± 5.97 11 .09 ± 5.66 
5 33.09 ± 2.77 12.32 ± 4.63 
• Measured in five vertical sections through suction blister roofs obtained from 
each of five subjects, per mm of epidennal basal ceU membrane. Presented as 
mean ± standard deviation. 
section were photographed at magnifications of X 2,800 and 
X 5,900. Recognition of individual Langerhans cells in adjacent step 
sections was achieved by comparing neighboring epidermal cells in 
high- and low-magnification negatives. 
Epidermal cells were prepared from one subject prior to UVB 
irradiation (Subject 1) and labeled with DA6.231 and secondary 
antibody conjugated to 15-nm gold particles in order to assess intra-
subject variation of MHC II labeling on dendritic epidermal cells. 
Single sections from 97 MHC II-positive dendritic epidermal cells 
were examined, which included both Langerhans and indetermin-
ate cells (cells identical to Langerha.l1s cells but lacking Birbeck 
granules). The number of gold particles was counted manually in 
each section and expressed per /1m of plasma membrane, measured 
by planimetry of the perimeter of MHC II-positive dendritic 
epidermal cells on electron micrographs (print magnification 
X 11,800). 
Effect of UVB on Epidermal Cell Surface MHC II Ex-
pression The effect of the course of UVB radiation was investi-
gated on surface MHC II expression by epidermal cells obtained 
from the five subjects. Epidermal cell suspensions were prepared 
from each volunteer before and after UV irradiation, labeled with 
DA6.231 and secondary antibody conjugated to 30-nm gold parti-
cles, sectioned, and the number of gold particles per /1m of plasma 
membrane determined on five different Langerhans cells. 
Statistics For statistical analysis, the analysis of variance was used 
to analyze both MHC II-positive cell numbers and Langerhans cell 
surface MHC II expression. A p value of < 0.05 was considered 
significant. 
RESULTS 
Quantification of MHC II-Positive Dendritic Epidermal 
Cells in Suction Blister Roofs The mean number of MHC 
II-positive dendritic epidermal cells per mm of epidermal basal cell 
plasma membrane in vertical sections through suction blister roofs 
was significantly reduced after UVB irradiation, (p < 0.001 analysis 
of variance [ANOVA]; Table I) . There were a small number of 
MHC II-positive nondendritic epidermal cells both before and after 
UVB exposure. These cells, which were readily identified as cells of 
the acrosyringium, were not counted. 
Distribution of Epidermal Cell Surface MHC II The mean 
thickness of 22 ultrathin sections of pale-gold interference color 
was 68.15 ± 0.72 mm (standard error). 
Assessment of step sections through 15 labeled Langerhans cells 
before and after UVB exposure (three Langerhans cells from each 
subject). sho.wed that the density of epidermal cell surface gold parti-
cles vaned httle among sections through a single cell. Gold particles 
appeared to be evenly distributed over the surface of individual cells 
with a small standard deviation (Figs 1 and 2; Table II). 
Examination of sections through 97 immunogold-labeled MHC 
II - positive epidermal cells from one individual revealed consider-
able variation in surface MHC II density between different epider-
mal cells (approaching 20 times), and this variation was normally 
distributed (Fig 3). There was no difference ill the density of cell 
surface MHC II between Langerhans and indeterminate cells, and 
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Figure 1. a -c) Three-step sec tions through a single Langerhans cell from unirradiated skin showing the ' f .' 
, , d 'b d ' um ormlty of surface MHC II DA6,231 primary antIbody and goa t anti -mouse secon aryantI 0 y cO(\Jugated to 30-nm gold particles d) B' 'b , . expression, using 
cytoplasm of the Langerhans cell that is labeled with 30-nm gold particles (arrow) (IJar, l/lm) , ,II eck glanules (arrowheads) within the 
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Figure 2. a -c) Three-step sections through a single L~ngerhans c~ll from irracliated skin showing uni f01:m surface MHC 11 expression (Langerhans cell is 
labeled with DA6.231 primary antibody and goa t anti -mouse antibody conjugated to 3D-nm gold particles) and normal ulti'astructural morphology . d) 
Birbeck granule (arrowhead) within the Langerhans cell cytoplasm (bar, 1,1m ). 
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Table II. Distribution of MHC II Antigens on 15 Langerhans Cells Before and After a Standard 6-Week Course of UVB Radiatio~ 
Pre UVB Post UVB 
LC Gold Particles/pm SDb Sections/LC' Gold Particles/Jim SDb Sections /LC' 
1 3.52 0.83 3 5.14 0.55 3 
2 4.35 0.62 3 5.74 0.50 3 
3 4.69 0.36 3 6.22 0.84 4 
4 4.82 0.54 4 6.48 0.69 3 
5 5.47 0.41 3 7.03 0.64 3 
6 6.21 0.76 3 7.44 1.06 3 
7 6.83 0.54 3 7.63 0.31 3 
8 6.95 1.06 3 8.17 0.26 3 
9 8.16 0.29 3 8.47 0.35 3 
10 8.16 0.98 5 11.45 1.44 3 
11 8.69 0.45 3 12.49 0.62 3 
12 9.36 0.92 3 13.14 0.78 3 
13 11.26 0.62 3 13.97 1.09 3 
14 13.94 1.30 3 14.16 0.78 3 
15 15.56 1.38 4 23.40 3.12 3 
• Data calculated as the mean number of 30-nm gold particles per 11m plasma membrane on step sections through individual Langerhans cells, three cells from each of five 
subjects . 
! 50, standard deviation. 
, LC, Langerhans cells. 
no evidence of separate populations of MHC II-positive epidermal 
cells expressing either a high or a low surface density of MHC II. 
Effect of UVB Phototherapy on Epidermal Cell Surface 
MHC II Expression Labeling of the plasma membrane of 25 
Langerhans cells (five from each subject) with DA6.231 following 
UVB irradiation showed a consistent increase compared with that 
prior to irradiation (Table III), and the difference was statistically 
significant (p < 0.05, ANOVA). Careful examination of both pre-
N° LC/lC 
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Figure 3. Histogram showing the frequency distribution of surface MHC 
II density on 97 epidermal cells from subject 1 labeled with DA6.231 and 
goat anti-mouse antibody conjugated to IS-nm gold particles. Shaded bars, 
Langerhans cells; unshaded bars, indeterminate cells. 
and post-UVE samples failed to demonstrate any MHC II-negative 
Langerhans or indeterminate cells. 
DISCUSSION 
The detailed study reported here used a highly sensitive immuno-
gold electron microscopic technique and clarifies the changes occur-
ring to MHC II expression on epidermal antigen-presenting cells 
fo llowing a therapeutic UVB regimen. 
Throughout, we attempted to minimize the sampling errors as-
sociated with the ultrastructural morphometric methods used in 
this study. For example, step sections through individual MHC 
II-positive Langerhans cells were examined to determine the precise 
surface distribution of MHC II. Because the gold label was evenly 
distributed over the surface of MHC II-positive cells, we concluded 
that ar~y one section of a la~eledcell was represent~tive of the whole 
cell wlth regards to quantlfication of surface antlgen density. Sec-
tions of pale-gold interference color were selected for ultrastruc-
tural examination because their thickness was assumed to be rela-
tively constant. Variations in section thickness might influence the 
label density, with MHC II-positive cells on thick sections appear-
ing more densely labeled than MHC II-positive cells on thin sec-
tions. The demonstration that sections of a pale-gold interference 
color were relatively uniform in thickness confirms that errors re-
lating to section thickness were minimal. 
There has been controversy as to whether the apparent reduction 
in Langerhans cell numbers observed using light microscopic tech-
niques after UVE exposure reflects a genuine decrease in cell num-
bers or simply a diminished expression of the surface antigen llsed to 
demonstrate them [10,11,20,21 ,22] . We have clearly demonstrated 
that therapeutic doses of UVE deplete human epidermis of MHC 
II - positive cells, and that residual Langerhans cells show a small but 
Table III. The Surface Density of MHC II Labeling on 
Langerhans Cell Surfaces Before and After a 
Standard 6-Week Course of UVB Radiation. 
Subject Pre UVB Post UVB 
1 8.24 ± 1.56 11.14 ± 3.85 
2 5.24 ± 0.67 5.86 ± 2.46 
3 5.02 ± 3.35 7.21 ± 2.46 
4 7.22 ± 2.68 8.18 ± 4.02 
5 5.17±1.34 11.16 ± 2.01 
• Mean number of 30-nm gold particles/11m plasma membrane ± standard de-
viation; n = 5. 
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significant increase in the surface densit~ of MHC II. The produc-
tion of cytokines by UV-irradlated kerattnocytes or the productlon 
of gamma-interferon as a result of minimal inflammation may playa 
role in increased MHC II expression by UV -irradiated Langerhans 
cells. The cause of the decrease in epidermal Langerhans cell num-
bers after therapeutic UVE irradiation is still uncertain. The possibil-
ities include damage to the Langerhans cdls or their migration from 
the epidermis. Although we observed no evidence of Langerhans 
cell damage in our ultrastructural immunogold study, it m ay not be 
possible to detect damaged Langerhans cells by this technique, be-
cause of the disruption of the epidermis entailed in the production of 
epidermal cell suspensions. 
Recently Ashworth et al [23] showed that PUVA therapy for 
psoriasis depleted epidermal Langerhans cells and reduced ill 1;lro 
alloantigen-presenting capacity of mixed epidermal cells. However, 
residual Langerhans cdls retained the normal surface HLA-DR and 
CDla expression, assessed by fluorescent flow cytometry, and the ill 
vitro alloantigen-presenting function on a per-cell basis was not 
altered. It is unclear, from that study or our own, whether Langer-
hans cells remaining in the epidermis after PUVA or UVE therapy 
represent either a UV -resistant subpopulation of Langer hans cells or 
cells that have recently migrated into the epidermis from a recircu-
lating pool of Langerhans cell precursors. Some investigators have 
reported the appearance following UVB exposure of CDla-
I-ILA-DR+ OKM5+ macrophages in the human epidermis, which 
displayed melanophagic activity and might activate suppressor T 
cells [24,25]. In our study, some UV-irradiated dendritic MHC 
II -positive epidermal cells were melanophagic and a small subset 
were highly dendritic. 
Both Langerhans cells and indeterminate cells w ere shown to 
possess a uniform distribution of MHC U over the whole cell sur-
face before and after UV irradiation. There are few reports concern-
ing the surface distribution of MHC II on epidermal cells by trans-
mission electron microscopy, perhaps because of the difficulties and 
tedium of repeatedly sectioning the same cell. However, our results 
agree with previous investigations using both transmission and 
scanning electron microscopy [26 - 28]. There was no evidence in 
our study that either the capping or clustering of low densities of 
MHC II occurred on epidermal cells, as suggested by Sontheimer et 
al [29] using an immunofluorescence technique. 
It has been suggested that HLA-DR - positive epidermal cells, 
including Langerhalls cells, may be divided into subsets expressing 
high or low levels of surface MHC II, and that indeterminate cells 
express uniformly high levels [30]. However, in this study, using 
the mouse anti-pan MHC U monoclonal antibody DA6.231 (HLA-
DP, -DQ, -DR), both types of cells expressed similar densities of 
surface MHC II, with a normaJly distributed variation between 
high and low levels of antigen expression. 
In conclusion, we have used a combination ofimmunohistochem-
istry and immu\1oe!ectron microscopy to assess the effects of a thera-
peutic DVE regimen on human MHC II-positive epidermal cells. 
W e have demonstrated a reduction in the number ofMHC II-posi-
tive epidermal cells after UVB radiation, which cannot be explained 
by the loss of cell surface antigen expression. 
We Ulould like to tlwllk Dr. K. Grty, Departfllellt of Cytogetlctics, Western General 
Hospital, Edinbllrgh for providillg DA6.231 lIIolloc/ollal ntllibody. 
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